Clinical Impact of Baseline Frailty Status and Residual Mitral Regurgitation After Transcatheter Edge‐to‐Edge Repair: Insights From the OCEAN‐Mitral Registry

Background The Clinical Frailty Scale (CFS) is a useful frailty marker for predicting clinical outcomes in patients undergoing invasive therapy. However, the clinical impact of CFS after transcatheter edge‐to‐edge repair in patients with mitral regurgitation (MR) remains unclear. This study aimed to elucidate the association between the baseline frail status defined by the CFS and clinical outcomes with or without postprocedural MR ≥2+ (post‐MR ≥2+) after transcatheter edge‐to‐edge repair. Methods and Results Based on a Japanese multicenter registry (OCEAN [Optimized Catheter Valvular Intervention]‐Mitral), data from 2078 patients with MR who underwent transcatheter edge‐to‐edge repair were analyzed. The patients were classified into 5 groups: CFS 1 to 3, 4, 5, 6, and ≥7. The procedural and clinical outcomes and post‐MR ≥2+ were compared among the groups. All‐cause mortality for up to 2 years was explored using Cox proportional hazards regression analysis. Although the rates of acute procedural success and post‐MR ≥2+ were similar, all‐cause mortality at 2 years was significantly increased across the 5 CFS categories (15.5%, 23.8%, 27.7%, 34.6%, and 48.8%, respectively, P <0.001). The incremental CFS categories and post‐MR ≥2+ were independent predictive risk factors of all‐cause mortality (all P <0.05). Among the patients with 5 CFS categories, the incidence of all‐cause mortality was higher in those with post‐MR ≥2+ than in those without (all P <0.05). Conclusions Although prognosis was poor in patients with higher CFS grade after transcatheter edge‐to‐edge repair, minimizing modifiable factors of residual MR is warranted to improve the clinical outcomes. Registration Information URL: https://center6.umin.ac.jp/cgi‐open‐bin/ctr/ctr_view.cgi?recptno=R000027188 ; Unique identifier: UMIN000023653.